The ASCI’s 2017 Young Physician-Scientist Awards

The ASCI congratulates its 2017 Young Physician-Scientist Award recipients, who will be recognized at the 2017 AAP/ASCI/APSA Joint Meeting and present their work at the ASCI’s Food and Science Evening on April 22, 2017.

Download the ASCI’s 2017 Food and Science Evening abstract book

Recipient Institution
Olujimi A. Ajijola, MD, PhD University of California, Los Angeles
Himisha Beltran, MD Weill Cornell Medical College
Ankit Bharat, MBBS, FACS Northwestern University Feinberg School of Medicine
Michael Chattergoon, MD, PhD Johns Hopkins University School of Medicine
Helen Y. Chu, MD, MPH University of Washington
Paul Cohen, MD, PhD The Rockefeller University
Matthew Steven Davids, MD, MMSc Dana-Farber Cancer Institute, Harvard Medical School
Robert Pickett Dickson, MD University of Michigan Medical School
Jennifer Alzos Downs, MD, MSc, PhD Weill Cornell Medical College
Maros Ferencik, MD, PhD Oregon Health & Science University
Gabriel Ghiaur, MD, PhD Johns Hopkins University
Ethan Michael Goldberg, MD, PhD Children’s Hospital of Philadelphia
Matthew Blake Greenblatt, MD, PhD Weill Cornell Medical College
Yogendra Kanthi, MD University of Michigan Medical School
Kory J. Lavine, MD, PhD Washington University School of Medicine
Jens G. Lohr, MD, PhD Dana-Farber Cancer Institute, Harvard Medical School
Matthew D. Neal, MD University of Pittsburgh School of Medicine
Sahar Nissim, MD, PhD Brigham and Women’s Hospital, Harvard Medical School
Edwin Ostrin, MD, PhD MD Anderson Cancer Center
Lale Ozcan, MD Columbia University Medical Center
Marta Peciña, MD, PhD University of Pittsburgh
Hallie C. Prescott, MD, MSc University of Michigan
Seth Rakoff-Nahoum, MD, PhD Boston Children’s Hospital, Harvard Medical School
Rajesh C. Rao, MD University of Michigan
Nataliya Razumilava, MD University of Michigan
Michael Satlin, MD, MS Weill Medical College of Cornell University
Robert W. Schnepp, MD, PhD Emory University School of Medicine
Natalie D. Shaw, MD, MMSc NIH, National Institute of Environmental Health Sciences
Matthew A. Sparks, MD Duke University School of Medicine
Cullen Mitsuo Taniguchi, MD, PhD The University of Texas MD Anderson Cancer Center
Sriram Venneti, MD, PhD University of Michigan Medical School
Philip A. Verhoef, MD, PhD University of Chicago
Taia Wang, MD, PhD Stanford University School of Medicine
Michael Emmerson Ward, MD, PhD NIH, National Institute of Neurological Disorders and Stroke
Brendon O. Watson, MD, PhD Weill Cornell Medicine
Marc Nathan Wein, MD, PhD Harvard Medical School, Massachusetts General Hospital
James Michael Wells, MD University of Alabama at Birmingham
Min Xie, MD, PhD University of Alabama at Birmingham
Kelley Yan, MD, PhD Columbia University Medical Center

Recipient of the 2017 Seldin~Smith Award: Omar Abdel-Wahab, MD

Dr. Abdel-Wahab

The American Society for Clinical Investigation (ASCI) is pleased to announce Omar Abdel-Wahab, MD, as the recipient of the 2017 Donald Seldin~Holly Smith Award for Pioneering Research. Dr. Abdel-Wahab is an Assistant Member at the Memorial Sloan Kettering Cancer Center, where he serves as Co-Director of the Hematology/Medical Oncology Fellowship Program in the Department of Medicine.

Dr. Abdel-Wahab will receive an unrestricted award of $30,000 to advance his academic efforts, and he will be recognized on April 22, 2017, as part of the AAP/ASCI/APSA Joint Meeting (April 21-23). Dr. Abdel-Wahab will deliver a scientific talk at the 2018 Joint Meeting.

Dr. Abdel-Wahab’s efforts have focused on the discovery and functional characterization of genetic abnormalities in common and rare forms of hematologic malignancies. His laboratory identified the functional effects of mutations in some of the most commonly mutated genes in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). These discoveries have resulted in ongoing clinical trials of novel targeted therapies for patients with MDS, AML, hairy cell leukemia, and histiocytosis.

“One major focus of Omar’s research includes studying the role of altered spliceosomal proteins in leukemia. His work has already advanced our understanding of this basic biological function and its alteration in cancer,” Ross L. Levine, MD, wrote in his letter supporting Dr. Abdel-Wahab’s nomination. “In addition to his seminal work in the MDS field relating to aberrant splicing, Omar helped to define the cell-of-origin of hairy cell leukemia, a question that has been debated for decades. More recently, he has helped to define the clinical efficacy and mechanisms of vemurafenib resistance in hairy cell leukemia. His insight, knowledge, and technical skills are incredibly advanced for a young investigator.”

Development of the Seldin~Smith Award began with the goal of connecting the legacies of two iconic figures in medicine — Donald Seldin (University of Texas Southwestern Medical Center) and Lloyd “Holly” Smith Jr. (University of California, San Francisco) — with exceptionally creative early-career physician-scientists. The ASCI is grateful to Drs. Seldin and Smith, who provided the inspiration for this Award through their storied careers of developing generations of outstanding physician-scientists.

Dr. Abdel-Wahab was selected from a group of exceptional nominees in the United States and abroad. The applicants were evaluated by a Selection Committee of current and former ASCI presidents: Mukesh K. Jain (Chair), Vivian G. Cheung, Charles L. Sawyers, Elizabeth M. McNally, and Stuart H. Orkin. Finalists were evaluated by an Advisory Committee comprising five physician-scientist luminaries: Joseph L. Goldstein (Chair), Michael S. Brown, Arthur Weiss, Stanley B. Prusiner, and Robert J. Lefkowitz.

The Seldin~Smith Award complements two prestigious ASCI awards (the Stanley J. Korsmeyer Award and the Harrington Prize for Innovation in Medicine) that recognize senior physician-scientists who have made major contributions to science, mentorship, and translation of discovery to clinical impact.

About the ASCI: Founded in 1908, the American Society for Clinical Investigation is one of the oldest and most esteemed nonprofit honor societies of physician-scientists. Membership is by election only, and only researchers who are 50 years of age or younger are eligible for nomination. Therefore, membership in the ASCI recognizes a researcher’s significant contributions, at a relatively young age, to the understanding of human disease. The Society counts among its ranks over 3,000 members, many of whom are leaders in academic medicine and industry. Many members have been recognized by election to the U.S. National Academy of Sciences and the U.S. National Academy of Medicine. The ASCI is also proud to have among its membership winners of the Nobel Prize and the Lasker Award. The Society self-publishes the prestigious Journal of Clinical Investigation, a top-tier biomedical journal, and JCI Insight, launched in late 2015. The ASCI holds its annual meeting with the Association of American Physicians and the American Physician-Scientists Association.

The 2017 Harrington Prize for Innovation in Medicine: Daniel J. Drucker, MD, Joel F. Habener, MD, and Jens J. Holst, MD, DMSc

International Harrington Prize Jointly Awarded to Three Recipients

Dr. Drucker

Dr. Habener

Dr. Holst

The fourth annual Harrington Prize for Innovation in Medicine has been jointly awarded to Daniel J. Drucker, MD (Mount Sinai Hospital, Canada), Joel F. Habener, MD (Massachusetts General Hospital, USA), and Jens J. Holst, MD, DMSc (University of Copenhagen, Denmark) for their discovery of incretin hormones and for the translation of these findings into transformative therapies for major metabolic diseases such as diabetes.

The Harrington Prize for Innovation in Medicine, established in 2014 by the Harrington Discovery Institute at University Hospitals (UH) in Cleveland, Ohio, and The American Society for Clinical Investigation (ASCI), honors physician-scientists who have moved science forward with achievements notable for innovation, creativity and potential for clinical application.

Drs. Habener and Holst are recognized for their discovery of the hormone glucagon-like peptide 1 (GLP-1) and Dr. Drucker for translating the discovery into breakthrough treatments for diabetes. The work of these three investigators, and in particular Dr. Drucker, has also resulted in the discovery and clinical development of glucagon-like peptide 2 (GLP-2) for intestinal disorders (short bowel syndrome).

“The work by this trio of investigators that spans the full spectrum from discovery to clinical impact is exemplary,” said Vivian Cheung, MD, Investigator of the Howard Hughes Medical Institute, Professor of Medicine at the University of Michigan, and 2016-2017 President of the ASCI. “This is precisely the type of bench-to-bedside advancements that The Harrington Prize seeks to recognize.”

A committee composed of members of the ASCI Council and the Harrington Discovery Institute Scientific Advisory Board reviewed 58 nominations from 49 institutions and five countries before selecting the 2017 recipients.

“We are pleased to join with the ASCI to honor Drs. Drucker, Habener and Holst for their contributions to medicine,” said Jonathan Stamler, MD, President of the Harrington Discovery Institute and the Robert S. and Sylvia K. Reitman Distinguished Chair in Cardiovascular Innovation at UH Cleveland Medical Center and Case Western Reserve University School of Medicine. “This remarkable trio exemplifies the best in medicine – from fundamental discovery through to breakthrough drugs in the clinic that impact the lives of millions of people around the world.”

In addition to sharing a $20,000 honorarium, Drs. Holst, Habener, and Drucker will jointly deliver The Harrington Prize Lecture at the 2017 Association of American Physicians/ASCI/American Physician Scientists Association Joint Meeting on April 21, and publish an essay in The Journal of Clinical Investigation.

Dr. Drucker received his MD from the University of Toronto in 1980, is currently a Senior Scientist at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, and Professor, University of Toronto. Dr. Habener received his MD in 1970 from the University of California Los Angeles and currently is Professor of Medicine at the Massachusetts General Hospital, Harvard Medical School. Dr. Holst received his MD in 1970 from the University of Copenhagen where he currently serves as Scientific Director, Novo Nordisk Foundation Center for Basic Metabolic Research.

The first recipient of The Harrington Prize for Innovation in Medicine, in 2014, was Dr. Harry Dietz, a pediatric cardiologist and genetics researcher from Johns Hopkins University School of Medicine. The Prize recognized Dr. Dietz’s contributions to the understanding of biology and treatment of Marfan syndrome, a disorder leading to deadly aneurysms in children and adults. The 2015 Prize recipient was Douglas R. Lowy, MD, Chief, Laboratory of Cellular Oncology, and Acting Director of the National Cancer Institute, in recognition of his discoveries that led to the development of the Human Papillomavirus (HPV) vaccine to prevent cervical cancer. The 2016 recipient of The Harrington Prize was Jeffrey M. Friedman, MD, PhD, of The Rockefeller University, New York City, for his discovery of leptin, which controls feeding behavior and is used to treat related clinical disorders.

Harrington Discovery Institute

The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio – part of The Harrington Project for Discovery & Development – aims to advance medicine and society by enabling our nation’s most inventive physician-scientists to turn their discoveries into medicines that improve human health. The institute was created in 2012 with a $50 million founding gift from the Harrington family and instantiates the commitment they share with University Hospitals to a Vision for a ‘Better World’.

The Harrington Project for Discovery & Development

The Harrington Project for Discovery & Development (The Harrington Project), founded in late February 2012 by the Harrington Family and University Hospitals of Cleveland, is a $300 million national initiative built to bridge the translational valley of death. It includes the Harrington Discovery Institute and BioMotiv, a for-profit, mission-aligned drug development company that accelerates early discoveries into medicines for benefit of society.

For more information about The Harrington Project and the Harrington Discovery Institute, visit: HarringtonDiscovery.org.

University Hospitals

Founded in 1866, University Hospitals serves the needs of over 1 million patients per year through an integrated network of 18 hospitals, more than 40 outpatient health centers and 200 physician offices in 15 counties throughout northern Ohio. The system’s flagship academic medical center, University Hospitals Cleveland Medical Center, located on a 35-acre campus in Cleveland’s University Circle, is affiliated with Case Western Reserve University School of Medicine. The main campus also includes University Hospitals Rainbow Babies & Children’s Hospital, ranked among the top children’s hospitals in the nation; University Hospitals MacDonald Women’s Hospital, Ohio’s only hospital for women; and University Hospitals Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. UH is home to some of the most prestigious clinical and research programs in the nation, including cancer, pediatrics, women’s health, orthopedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, dermatology, transplantation and urology. UH Cleveland Medical Center is perennially among the highest performers in national ranking surveys, including “America’s Best Hospitals” from U.S. News & World Report. UH is also home to Harrington Discovery Institute at University Hospitals – part of The Harrington Project for Discovery & Development. UH is the second largest employer in northern Ohio with 26,000 employees. For more information, go to UHhospitals.org.

The 2017 Stanley J. Korsmeyer Award: James E. Crowe Jr., MD

James E. Crowe Jr., MD, is the recipient of the 2017 American Society for Clinical Investigation’s (ASCI) Stanley J. Korsmeyer Award, in recognition for his research leading to the development of innovative technologies for the isolation and study of antiviral antibodies and for significantly advancing the fields of virology and immunology.

Dr. Crowe’s research group has isolated human monoclonal antibodies for many pathogenic viruses, including Zika, HIV, dengue, influenza, Ebola, norovirus, respiratory syncytial virus (RSV), rotavirus, and others. Antibodies discovered by his laboratory currently are in clinical development programs for several targets. His research has led to a number of patents and licensures of antibodies and vaccines, in particular for RSV, that have progressed to clinical trials.

Dr. Crowe drew inspiration from his father, a pediatric radiologist. Seeing his father read films intrigued him and later inspired his interest in structure-based design of vaccine development and computational immunology. He received his BS from Davidson College and became interested in service and global issues. He received his MD in 1987 from the University of North Carolina School of Medicine, where he also completed his pediatric residency in 1990. He worked on infectious diseases in West and East Africa, and this experience prompted him to think about how to have a broader impact on the diseases affecting these populations.

In 1995, he did a postdoctoral fellowship under Dr. Robert M. Chanock at the National Institutes of Health, where he worked on developing vaccines for RSV. He said, “I enjoyed the vaccine development work, but I was always thinking, ‘How does the immune system work? What is it that we are trying to accomplish with these vaccines? And are these vaccines going to trigger the types of responses we want?’ ” Following this five-year laboratory fellowship, he did a clinical fellowship in pediatric infectious diseases at Vanderbilt University Medical Center leading to board certification in that field. He started his faculty life at Vanderbilt as an Assistant Professor in Pediatrics and Microbiology and Immunology in 1996 and became Associate Professor in 2001. One of his major initial efforts was the development of a technique for generating recombinant human monoclonal antibodies to rotavirus from single antigen-specific B cells. This technique was then expanded to generate monoclonal antibodies against other viruses, including poxviruses. Presently, his laboratory is working with over 50 targets, most recently Zika, Ebola, and dengue.

Extending his work as a scientist, Dr. Crowe is also passionate about mentoring. He has received awards for mentoring postdoctoral fellows at Vanderbilt and has trained a large number of successful scientists at the pre- and postdoctoral level, with many of his trainees obtaining faculty positions at Vanderbilt and elsewhere.

Dr. Crowe is Professor of Pediatrics, Pathology, Microbiology and Immunology and the Ann Scott Carell Chair at Vanderbilt University, where he is also Director of the Vanderbilt Vaccine Center. Dr. Crowe was elected to the ASCI in 2004, the Association of American Physicians in 2009, and the National Academy of Medicine in 2014. In 2016, he was awarded Vanderbilt University’s John H. Exton Award, for research leading to innovative biological concepts.

Election of new members, 2017

The ASCI is pleased to report the results of a recent ballot to the Active segment of the membership, which asked voters to approve the Council’s recommendations for membership nominees to be elected this year. The vote, audited and confirmed late last week, returned overwhelmingly in favor of the recommendations.

The ASCI will welcome 64 new members this year. This new class of members is a remarkable and accomplished group of physician-scientists representing a diverse range of disciplines, specialties, and institutions.

The ASCI’s class of 2017

Member Institution Specialty
Abdulkadir, Sarki A. Northwestern University Feinberg School of Medicine Pathology
Alizadeh, Ash Stanford University School of Medicine Internal Medicine
Arora, Vineet M. University of Chicago Pritzker School of Medicine Internal Medicine
Auerbach, Andrew D. University of California, San Francisco, School of Medicine Internal Medicine
Bass, Adam J. Harvard Medical School, Dana-Farber Cancer Institute Medical Oncology
Behrens, Edward M. University of Pennsylvania School of Medicine Pediatrics
Beroukhim, Rameen Harvard Medical School, Dana-Farber Cancer Institute Medical Oncology
Bilimoria, Karl Northwestern University Feinberg School of Medicine Surgical oncology
Bose, Ron Washington University in St. Louis School of Medicine Oncology
Bowler, Russell Paul National Jewish Health Internal Medicine
Calakos, Nicole Duke University School of Medicine Neurology
Chandarlapaty, Sarat Memorial Sloan Kettering Cancer Center Internal Medicine
Chi, Ping Memorial Sloan Kettering Cancer Center Medicine
Corcoran, Ryan B. Harvard Medical School, Massachusetts General Hospital Oncology
Crompton, Peter D. NIH, National Institute of Allergy and Infectious Diseases Internal Medicine
Cypess, Aaron M. NIH, National Institute of Diabetes and Digestive and Kidney Diseases Internal Medicine
Diehn, Maximilian Stanford University School of Medicine Radiation Oncology
Dimick, Justin University of Michigan Medical School Surgery
Dransfield, Mark T. University of Alabama at Birmingham School of Medicine Internal Medicine
Feldman, Brian J. Stanford University School of Medicine Pediatrics
Feldstein, Ariel E. University of California, San Diego, School of Medicine Pediatrics
Fernandez-Zapico, Martin E. Mayo Clinic Cancer Biology
Fornoni, Alessia University of Miami Miller School of Medicine Internal Medicine
Fry, Terry J. NIH, National Cancer Institute Pediatrics
Galindo, Rene L. University of Texas Southwestern Medical Center Pathology
Gleason, Thomas L. G. University of Pittsburgh School of Medicine Surgery
Greka, Anna Harvard Medical School, Brigham & Women’s Hospital Medicine
Habtezion, Aida Stanford University School of Medicine Medicine
Haining, W. Nicholas Harvard Medical School, Dana-Farber Cancer Institute Pediatrics
Han, MeiLan University of Michigan Medical School Pulmonology
Herzog, Erica L. Yale School of Medicine Pulmonology
Jaffrey, Samie R. Weill Cornell Medical College Pharmacology
Jagsi, Reshma University of Michigan Medical School Radiation Oncology
Kirkpatrick, Beth Diane University of Vermont College of Medicine Internal Medicine
Kottilil, Shyamasundaran University of Maryland School of Medicine Internal Medicine
Krupnick, Alexander S. University of Virginia School of Medicine Surgery
Kundu, Mondira St. Jude Children’s Research Hospital Pathology
Kurtis, Jonathan David Brown University Medical School Pathology
Lam, Wilbur A. Emory University School of Medicine Pediatrics
Liu, George Y. Cedars Sinai Medical Center Pediatrics
Lovly, Christine M. Vanderbilt University School of Medicine Medical Oncology
Machado, Roberto University of Illinois at Chicago Internal Medicine
Majeti, Ravindra Stanford University School of Medicine Internal Medicine
Mody, Lona University of Michigan Medical School Aging
Musunuru, Kiran University of Pennsylvania School of Medicine Cardiovascular Medicine
Muthukumar, Thangamani Weill Cornell Medical College Nephrology
Pandrea, Ivona University of Pittsburgh School of Medicine Pathology
Parikh, Samir M. Harvard Medical School, Beth Israel Deaconess Medical Center Medicine
Patel, Manesh R. Duke University School of Medicine Cardiovascular Disease
Perencevich, Eli N. University of Iowa Carver College of Medicine Internal Medicine
Phipatanakul, Wanda Harvard Medical School, Boston Children’s Hospital Pediatrics
Ramalingam, Suresh Sakkarai Emory University School of Medicine Medical Oncology
Richards, John Brent McGill University Faculty of Medicine Epidemiology
Sampson, John H. Duke University Medical Center Neurosurgery
Sarantopoulos, Stefanie Duke University School of Medicine Medicine
Schaaf, Christian P. Baylor College of Medicine Medical Genetics
Schimmer, Aaron David University of Toronto Faculty of Medicine Internal Medicine
Seeley, William Ward University of California, San Francisco, School of Medicine Neurology
Sipkins, Dorothy Duke University Medical Center Cancer Biology
Steinman, Michael A. University of California, San Francisco, School of Medicine Geriatrics
Wang, Liewei Mayo Clinic Cancer Biology
White, Douglas Blakemore University of Pittsburgh School of Medicine Critical Care Medicine
Wolf, Matthew Joseph University of Virginia School of Medicine Internal Medicine
Yang, Xiangdong William University of California, Los Angeles, David Geffen School of Medicine Psychiatry

Call for Council nominations, 2017

The Society is seeking nominations for four vacancies on the ASCI Council: Vice President (4-year term, spring 2017-2021) and three Councilor positions (3-year term, 2017-2020).

All Council members are expected to support the activities of and attend the ASCI annual meeting, and to participate in the general governance of the Society, including two in-person meetings (fall and spring, coordinate with the annual meeting), and conference calls (typically every other month). All Council members participate in the review of membership nominations.

The Vice President transitions to President-Elect in year 2 and President in year 3. For the 2nd through 4th years of this position, this member is expected to participate significantly in matters related to the Joint Meeting. In the Presidential year (year 3), the member convenes a face-to-face Council meeting and oversees related review processes for nominations, notably including those to membership. The President works closely with the Association of American Physicians to create the annual meeting program, and the member presents the traditional Presidential Address at the meeting. In year 4, the President transitions to Immediate Past President, serving as an advisor to the current President and with full Council responsibilities and privileges.

The Council is supported by an Executive Director, Managing Director, and other staff members who oversee the day-to-day operations of the Society and effect initiatives as directed by the Council.

Members who will be 55 or younger in 2020 are eligible for nomination. Nominations may be submitted online through February 14, 2017, at 11:59 PM EST and consist of a 250-word summary of accomplishments accompanied by an NIH-style brief biosketch (PDF only). If the nomination is intended for a specific vacancy, please note this in the nomination comments.

Members must submit nominations through their member accounts.

Call for nominations: 2017 Young Physician-Scientist Awards

Nominations for 2017

We are pleased to call for nominations for the ASCI’s 2017 Young Physician-Scientist Awards. This is an excellent opportunity for a young faculty member to be recognized at the 2017 Joint Meeting.

We seek nominations of outstanding physician-scientists who have recently received their first faculty appointment (preferably in the last 5 years). Nominees must be funded by a current NIH K or equivalent career-development award (in or outside the United States). However, we welcome nominations of NIH intramural physician-scientists on the basis of their appointment only.

Those selected for this Awards program will:

  • receive a $500 honorarium
  • attend the 2017 Joint Meeting, April 21-23, at the Fairmont Chicago
  • attend the invitation-only ASCI President’s Reception on Friday, April 21
  • present their work at the ASCI’s Food & Science Evening, Saturday, April 22

Up to 40 Awards will be given for 2017. The following materials are required for nominations, which must be submitted online on or before the deadline, January 16, 2017, at 11:59 pm, U.S. Eastern:

Nominations can only be made by ASCI members through their online accounts.

Call for nominations, 2017 Stanley J. Korsmeyer Award

Nominees for the Stanley J. Korsmeyer Award must be ASCI members who are 55 years of age or younger as of January 1, 2017. They shall have made significant contributions to biomedical science and shall have adhered to the principles of scientific excellence that the ASCI exemplifies. The nominee should have a record that reflects high standards of intellectual integrity, a deep and abiding respect for the community of biomedical scientists, and a strong commitment to mentoring the next generation of physician-scientists. Prior nominees may be re-nominated. However, current ASCI Council members and prior Award recipients may not be nominated.

Nominations consist of:

  • a summary of the nominee’s accomplishments (in plain text, not to exceed 250 words),
  • a brief NIH biosketch (as a PDF),
  • and a trainee table (preferred as a PDF).

Nominations must be submitted by ASCI members through their online accounts.

The deadline for nominations is October 24, 2016, at 11:59 PM EDT.

Nominations for 2017 membership

Nominations for 2017 membership may be submitted through September 21, 2016. Proposers and supporters of nominations should review the Membership Nomination Guide carefully. Questions regarding nominations should be sent by e-mail to staff@the-asci.org.

Note to submitters: The ASCI sends acknowledgment of submissions by e-mail after they have been reviewed and found to be complete. Submitters can check the status of their submissions (nominations and support forms) online by accessing their member accounts.

Submitting nominations

To ensure proper tracking of nominations, all information and documents must be supplied online.
  • First, access your member account
  • After you have logged in to your account, select the “Nominations” tab, then search the nominee database. Links will appear in search results to guide you in the next steps.
  • Your nominee may already be in the ASCI database because the nominee was previously nominated or because a nomination or support form has been started for the nominee for this nomination cycle.

Proposers: Once you have supplied the requested information about your nominee (name, contact information, etc.), you will be able to upload required documents. You will also be able to add Seconder and General Supporter information to the nomination, although supporters will need to supply their comments via their own member accounts.

Seconder and General Supporters: Forms may be drafted and submitted online after selecting the applicable nominee from search results or after adding requested information about the nominee you are supporting. (NOTE: General Supporters who are not ASCI members may complete the nomination support template and e-mail it to for handling. Please indicate clearly your contact information and the name and institution of the nominee you are supporting.)

Further clarification

  • Age criterion for Active and Foreign Associate nominees. Nominees in these categories must be age 50 or younger as of January 1, 2017.
  • Exceptions to the age criterion cannot be made. Although the ASCI Council understands that a nominee’s progress may have been delayed because of unavoidable or extreme circumstances, the Council has on multiple occasions discussed exceptions and concluded from each discussion that no policy could be implemented fairly and durably.
  • Limit on number of nominations per nominee. The number of nominations per nominee is limited to 3, with the following exception: In 2013 the age limit for eligibility was increased from age 45 to age 50 or younger. In recognition of this revision, Active and Foreign Associate candidates who reached 3 nominations before or during the 2013 nomination cycle may be nominated one more time (for a maximum of 4 nominations) if they meet the following age criteria: this cycle (2017), age 49 to 50; 2018, age 50.
  • Limit on number of nominations proposed, seconded, or supported. There is no limit to the number of nominations a member may propose or support (either as Seconder or General Supporter).
  • Ph.D.-only candidates. Active and Foreign Associate nominations are, per the ASCI’s bylaws, restricted to physicians.
  • M.D.-equivalent candidates are eligible for nomination.
  • Faculty appointment versus nominee’s country of residence. The distinction between Active and Foreign Associate nominations is made on the basis of residence, not faculty appointment. Active nominees must reside in the U.S. or Canada. Candidates residing elsewhere should be nominated in the Foreign Associate category.
  • In press or accepted manuscripts can be included in a nominee’s bibliography. However, manuscripts submitted or in review should generally not be listed.

Call for nominations, 2017 Harrington Prize for Innovation in Medicine

National and international nominations are being sought for the fourth annual Harrington Prize for Innovation in Medicine, which honors a physician-scientist who has moved science forward with achievements notable for innovation, creativity and potential for clinical application.

The deadline for nominations is August 29, 2016. For nomination guidelines and online submission of nominations, visit: HarringtonDiscovery.org/ThePrize.

The Harrington Prize, which carries a $20,000 honorarium, is a collaboration between The American Society for Clinical Investigation (ASCI), one of the nation’s oldest and most respected medical honor societies, and the Harrington Discovery Institute at University Hospitals in Cleveland, Ohio – part of The Harrington Project for Discovery & Development. The Harrington Discovery Institute is a nonprofit institute dedicated to supporting physician-scientists in their work to transform bench discoveries into promising leads that may result in novel therapeutics.

Both organizations recognize the obstacles associated with turning discoveries into medicines that improve human health, and they are eager to highlight those who have navigated the path successfully or whose work has led to novel treatments.

A committee composed of members of the ASCI Council and the Harrington Discovery Institute Scientific Advisory Board will review the nominations and select the awardee.

In addition to receiving the honorarium, the 2017 recipient will deliver The Harrington Prize Lecture at the 2017 Joint Meeting of the Association of American Physicians (AAP), the ASCI, and the American Physician Scientists Association (APSA) on April 21-23, 2017, will participate at the 2017 Harrington Discovery Institute annual symposium (May 24-25, 2017), and will publish a personal essay in the Journal of Clinical Investigation.

Previous award winners are Jeffrey M. Friedman, MD, PhD (2016), Douglas R. Lowy, MD (2015), and Harry C. Dietz, MD (2014). For questions or more information about the nomination requirements, visit HarringtonDiscovery.org/ThePrize or contact Natalie Haynes, Harrington Discovery Institute Program Director, at Natalie.Haynes@HarringtonDiscovery.org.